Surveillance for malignant progression of LI-RADS version 2017 category 3/4 nodules using contrast-enhanced ultrasound. Huang H, Li CQ, He DN, Ruan SM, et al. Eur Radiol 2023;33:9336-9346.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang H, Li CQ, He DN, Ruan SM, et al. Surveillance for malignant progression of LI-RADS version 2017 category 3/4 nodules using contrast-enhanced ultrasound. Eur Radiol 2023;33:9336-9346.
PMID: 37405501